Evidence map›Paper›PMID 35011373›Full record

ReviewMolecules (Basel, Switzerland)2021

A Glossary for Chemical Approaches towards Unlocking the Trove of Metabolic Treasures in

Jianye Zhang, Heba Ali Hassan, Usama Ramadan Abdelmohsen, Eman Maher Zahran

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. 2-Amino-3-Chlorobenzoic Acid fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Jianye ZhangKey Laboratory of Molecular Target & Clinical Pharmacology and the State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, China.ORCID 0000-0001-5242-3687
Heba Ali HassanDepartment of Pharmacognosy, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.ORCID 0000-0002-2631-5831
Usama Ramadan AbdelmohsenDepartment of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Eman Maher ZahranDepartment of Pharmacognosy, Faculty of Pharmacy, Deraya University, Universities Zone, New Minia City 61111, Egypt.
Deraya UniversityGuangzhou Medical University · CNSohag University · EG

Funding

Fund of Guangdong Education Department 2021ZDZX2006National Key R&D Program of China 2021YFE0202000National Natural Science Foundation of China U1903126
6 · The paper itself

Abstract

Actinobacterial natural products showed a critical basis for the discovery of new antibiotics as well as other lead secondary metabolites. Varied environmental and physiological signals touch the antibiotic machinery that faced a serious decline in the last decades. The reason was exposed by genomic sequencing data, which revealed that

Indexed as

ActinobacteriaAnti-Bacterial AgentsGenes, BacterialSecondary MetabolismAnti-Bacterial AgentsActinomycetesantibiotics biosynthesisbiological potentialcryptic geneselicitors

Identifiers

PMID35011373
PMCPMC8746466
OpenAlexW4200339120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.